Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes

Diabetes. 2003 Sep;52(9):2239-48. doi: 10.2337/diabetes.52.9.2239.

Abstract

To assess the role of insulin receptor (IR) substrate (IRS)-2 in insulin action and resistance in the liver, immortalized neonatal hepatocyte cell lines have been generated from IRS-2(-/-), IRS-2(+/-), and wild-type mice. These cells maintained the expression of the differentiated liver markers albumin and carbamoyl phosphate synthetase, as well as bear a high number of IRs. The lack of IRS-2 did not result in enhanced IRS-1 tyrosine phosphorylation or IRS-1-associated phosphatidylinositol (PI) 3-kinase activity on insulin stimulation. Total insulin-induced PI 3-kinase activity was decreased by 50% in IRS-2(-/-) hepatocytes, but the translocation of PI-3,4,5-trisphosphate to the plasma membrane in these cells was almost completely abolished. Downstream PI 3-kinase, activation of Akt, glycogen synthase kinase (GSK)-3 (alpha and beta isoforms), Foxo1, and atypical protein kinase C were blunted in insulin-stimulated IRS-2(-/-) cells. Reconstitution of IRS-2(-/-) hepatocytes with adenoviral IRS-2 restored activation of these pathways, demonstrating that IRS-2 is essential for functional insulin signaling in hepatocytes. Insulin induced a marked glycogen synthase activity in wild-type and heterozygous primary hepatocytes; interestingly, this response was absent in IRS-2(-/-) cells but was rescued by infection with adenoviral IRS-2. Regarding gluconeogenesis, the induction of phosphoenolpyruvate carboxykinase and glucose 6-phosphatase by dibutyryl cAMP and dexamethasone was observed in primary hepatocytes of all genotypes. However, insulin was not able to suppress gluconeogenic gene expression in primary hepatocytes lacking IRS-2, but when IRS-2 signaling was reconstituted, these cells recovered this response to insulin. Suppression of gluconeogenic gene expression in IRS-2-deficient primary hepatocytes was also restored by infection with dominant negative Delta 256Foxo1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Animals, Newborn
  • Antigens, Polyomavirus Transforming / genetics
  • Cell Line, Transformed
  • Female
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Gluconeogenesis / physiology
  • Glucose-6-Phosphatase / metabolism
  • Glycogen Synthase / metabolism
  • Glycogen Synthase Kinase 3 / metabolism
  • Hepatocytes / cytology
  • Hepatocytes / metabolism*
  • Hypoglycemic Agents / pharmacology
  • Insulin / pharmacology
  • Insulin Receptor Substrate Proteins
  • Insulin Resistance / physiology*
  • Intracellular Signaling Peptides and Proteins
  • Isoenzymes
  • Male
  • Mice
  • Mice, Mutant Strains
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphatidylinositol Phosphates / biosynthesis
  • Phosphoenolpyruvate Carboxykinase (GTP) / metabolism
  • Phosphoproteins / genetics*
  • Phosphoproteins / metabolism*
  • Pregnancy
  • Protein Kinase C / metabolism
  • Protein Serine-Threonine Kinases*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • Retroviridae / genetics
  • Signal Transduction / physiology
  • Transcription Factors / metabolism

Substances

  • Antigens, Polyomavirus Transforming
  • Forkhead Box Protein O1
  • Forkhead Transcription Factors
  • Foxo1 protein, mouse
  • Hypoglycemic Agents
  • Insulin
  • Insulin Receptor Substrate Proteins
  • Intracellular Signaling Peptides and Proteins
  • Irs2 protein, mouse
  • Isoenzymes
  • Phosphatidylinositol Phosphates
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Transcription Factors
  • phosphatidylinositol 3,4,5-triphosphate
  • Glycogen Synthase
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • protein kinase C zeta
  • Protein Kinase C
  • protein kinase C lambda
  • Glycogen Synthase Kinase 3
  • Glucose-6-Phosphatase
  • Phosphoenolpyruvate Carboxykinase (GTP)